Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Journey
Companies On The Road
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Journey
Companies On The Road
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
Nice Insight Reports
2022 Sterile
2023 Cell & Gene Therapy
2023 mAb and Recombinant Protein
2024 API
2024 OSD
2024 ADC
2024 mRNA
2024 Mammalian Cell Culture
2024 Microbial Cell Culture
2024 Plasmids
2024 Gene Therapy
2024 Cell Therapy
2024 Sterile
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Approval
29 Articles Available
0
2
Can't find what you're looking for? Try our
advanced search
.
Migraine
Biohaven Announces NURTEC® ODT Receives First Global Approval Outside the U.S. For Prevention of Migraine
PR-M12-21-01
Drug Approval
Farxiga Approved in the US for the Treatment of Heart Failure in Patients
PR-M05-20-NI-015
Drug Development
LYNPARZA® (olaparib) Approved by FDA as First-Line Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer
PR-M01-20-NI-003
Drug Approval
Calquence Approved in the US for Adult Patients with Chronic Lymphocytic Leukemia
PR-M11-19-NI-037
Drug Approval
Qtrilmet Approved in the EU for the Treatment of Type-2 Diabetes
PR-M11-19-NI-020
Vaccine Approval
Merck’s ERVEBO® [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union
PR-M11-19-NI-011
Approval
Novartis Gets European Approval to Update Cosentyx Label to Include Dosing Flexibility in Ankylosing Spondylitis
PR-M10-19-NI-036
FDA Approval
Janssen Announces U.S. FDA Approval of STELARA® (ustekinumab) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
PR-M10-19-NI-032
Approval
Farxiga Approved in the US to Reduce the Risk of Hospitalization for Heart Failure in Patients with Type-2 Diabetes
PR-M10-19-NI-029
Approval
Glenmark Receives Approval for Combination of Remogliflozin Etabonate and Metformin Hydrochloride for Adults With Type 2 Diabetes in India
PR-M08-19-NI-067
Launch
Alcon to Launch PRECISION1 Daily Disposable Contact Lenses as it Continues to Deliver on Vision Care Pipeline
PR-M08-19-NI-053
FDA Fast Track
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
PR-M06-19-NI-058
Drug Approval
Emflaza Now Approved for Treatment of Young Children
PAO-M06-19-NI-011
FDA Approval
FDA Approves First Anticoagulant Blood Thinner for Use in Children
PAO-M05-19-NI-028
Approval
Triple Combination Treatments for Multiple Myeloma Approved in Europe
PAO-M05-19-NI-027
Prequalification Approval
Abbott Receives WHO Prequalification Approval for Breakthrough HIV Point-of-Care Test
PR-M05-19-NI-017
Approval
Roche Gets New EU Approval for MabThera
PAO-M03-19-NI-027
Approval
European Commission Approved Tecentriq/Avastin Combination Therapy for Lung Cancer
PAO-M03-19-NI-018
Pediatric
Novo Nordisk Files for a Label Update for Fiasp® to the EMA and the FDA Seeking Approval for Use in Children and Adolescents
PR-M03-19-NI-007
Stem Cells
Second Study with Induced Pluripotent Stem Cells is Approved in Japan
PAO-M02-19-NI-020
Clinical Trials
Avapritinib Receives Phase III Clinical Trial Approval for GIST in China
PR-M02-19-NI-038
Approval
Novel Intrasaccular Aneurysm Treatment Device Receives FDA PMA Approval
PR-M01-19-NI-028
Drug Approval
AstraZeneca and FibroGen Receive First Approval for Anemia Drug in China
PAO-M12-18-NI-014
Approval
World-first Approval For Multiple Myeloma Drug APLIDIN(R)
PR-M12-18-NI-055
«
0
2
»